Adil Belrhzal: Visionary Leadership in Pharma Driving Growth and Innovation in Morocco and Beyond

Adil Belrhzal is a globally esteemed executive and Managing Director of Dislog Healthcare overseeing Morocco and export markets. As Vice President of the Fédération Marocaine de l’Industrie et de l’Innovation Pharmaceutiques (FMIIP) and an active member of the international pharma experts network, Adil exemplifies strategic leadership and operational excellence within the pharmaceutical sector.

Proven Excellence through Corporate Leadership Programs

Adil’s leadership prowess is anchored in a distinguished record of successful corporate programs from top universities worldwide. His training includes Leadership & Digital Transformation (ESSEC – Morocco, Singapore, Paris), Business Leadership and Financial Fluency (Duke University), Managing Director Readiness (BTS), and Harvard’s BUD Acceleration Program. These academic credentials complement his practical skills, empowering him to lead transformation and growth in complex markets.

Award-Winning Performance and Industry Recognition

Adil’s leadership and initiatives have earned him multiple prestigious awards across EEMEA and North Africa, recognizing excellence in talent development, commercial operations, oncology leadership, digital innovation, and cultural diversity. Notable accolades include the EEMEA Oncology Leadership Award for Executional Excellence, the North Africa Award for Successful Product Launches, and continuous recognition for strategic marketing and commercial best practices.

Driving Dislog Healthcare’s Transformation and Growth

Since 2022, Adil has driven Dislog Healthcare’s pharma business (Steripharma and Kosmopharm) to new heights. He has successfully repositioned the company from the 56th to the 13th rank in Morocco’s pharmaceutical industry within three years and achieved integration among the Top 500 Companies shortly after acquisition. Under his direction, Dislog Healthcare received the COFACE Quality Label (2025), reflecting outstanding brand performance and regulatory compliance.

Adil leveraged group synergies to position Dislog Healthcare as a Comprehensive and Full healthcare service provider. His foresight includes a clear 2030 vision aimed at entering Morocco’s top 10 pharma companies.

Significant Impact in Leadership Roles

Prior to Dislog, Adil led as Managing Director and Commercial and Business Operation Director the MSD North West Africa Cluster. Thanks to his leadership, he implemented a new operating model boosting the cluster performance, innovation access, and reimbursement strategies. Under his tenure, the cluster saw an outstanding sales performance and marked improvements in working capital efficiency and market rankings.

His transformative leadership was exemplified by steering the successful MSD/Organon spin-off, driving digital transformations through data analytics, and pioneering talent development programs recognized as EEMEA best practices. Adil was also a key member of the EEMEA Leadership Team and strategic forums, fostering collaboration and growth across multiple regions.

Early Career Foundations and Growth

Beginning his career in sales and brand management roles with African and Middle Eastern pharmaceutical companies, Adil quickly demonstrated his expertise through high-paced portfolio growth, strategic launches, and market share gains. His early roles included distinguished performances with local and multinational companies, where he contributed to significant oncology and specialty care advancements in Morocco and French-speaking Africa.

His ability to build effective teams, implement Go-to-Market strategies, and lead alliance management excellence has been recognized repeatedly, highlighting his consistent impact on pharma markets across 23 French-speaking countries.

Academic Credentials and Professional Memberships

Adil holds a Master’s degree in Raw Material Optimization and a Bachelor’s in Technical Analysis and Quality Control from Hassan 1st University, Morocco. His career achievements are supported by active roles in various professional bodies, including the FMIIP Vice Presidency, Dislog Group COMEX membership, EEMEA leadership team,Emergent Market Strategic Alliances Project key member, Global Pharma Experts Network Member and international pharma alliances.

Championing Local Sovereignty and Innovation

An outspoken advocate for local health sovereignty, Adil champions the use of generics as crucial to sustainable healthcare development. His recent nomination as FMIIP Vice President emphasizes his role in shaping Morocco’s pharma future strategically. His thought leadership extends to moderating panels for the International Federation of Pharmaceutical Wholesalers, focusing on distributor-manufacturer collaboration in Africa.

Conclusion

Adil Belrhzal combines visionary leadership, scientific acumen, and strategic business insight to transform pharmaceutical enterprises at scale. His stellar track record of awards, successful expansions, and profound influence in a competitive industry marks him as a top-tier global pharma executive delivering sustainable impact across Africa and beyond.